Please login to the form below

Not currently logged in


This page shows the latest ivacaftor news and features for those working in and with pharma, biotech and healthcare.

Vertex's two-drug cystic fibrosis treatment cleared in US

Vertex's two-drug cystic fibrosis treatment cleared in US

or who have at least one mutation that is responsive to tezacaftor/ivacaftor. ... It is also conducting trials with a regimen that swaps ivacaftor for another compound, VX-561, which could make once-daily dosing an option.

Latest news

More from news
Approximately 6 fully matching, plus 18 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....